Gamida Cell Completes Rolling Biologics License Application Submission to the FDA for Omidubicel

Omidubicel is a first-in-class, advanced NAM-enabled stem cell therapy candidate being evaluated as the first potential allogeneic advanced cell therapy donor source for patients with blood cancers in need of a transplant Omidubicel has Orphan...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news